BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7911139)

  • 1. Contribution of serotonin neurotoxins to understanding psychiatric disorders: the role of 5-HT2 receptors in schizophrenia and antipsychotic activity.
    Schmidt CJ; Kehne JH; Carr AA; Fadayel GM; Humphreys TM; Kettler HJ; McCloskey TC; Padich RA; Taylor VL; Sorensen SM
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():25-32. PubMed ID: 7911139
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dopamine D2 and serotonin 5HT2 receptors: functions, interactions and clinical consequences in schizophrenia].
    Guise S; Soubrouillard C; Blin O
    Encephale; 1997 Apr; 23 Spec No 2():10-6. PubMed ID: 9273300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroleptics and serotonin].
    Hery F; Hamon M
    Encephale; 1993; 19(5):525-32. PubMed ID: 7905821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression to ecstasy. The Neuropharmacology of Serotonin sponsored by the New York Academy of Sciences, New York, NY, USA, July 10-13, 1989.
    Whitaker-Azmitia PM
    New Biol; 1989 Nov; 1(2):145-8. PubMed ID: 2577368
    [No Abstract]   [Full Text] [Related]  

  • 5. Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA.
    Rattray M
    Essays Biochem; 1991; 26():77-87. PubMed ID: 1685707
    [No Abstract]   [Full Text] [Related]  

  • 6. [Psychopharmacologic approaches to schizophrenic psychoses].
    Giacardy-Paty M; Soubrouillard C; Blin O
    Encephale; 1995 Jun; 21 Spec No 3():3-8. PubMed ID: 7628339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice.
    Stahl SM; Shayegan DK
    J Clin Psychiatry; 2003; 64 Suppl 19():6-12. PubMed ID: 14728084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional versus novel antipsychotics: changing concepts and clinical implications.
    Remington G; Chong SA
    J Psychiatry Neurosci; 1999 Nov; 24(5):431-41. PubMed ID: 10586534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizophrenia: into the next millennium.
    Jones B
    Can J Psychiatry; 1993 Sep; 38 Suppl 3():S67-9. PubMed ID: 7902776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurobiology of cognition in schizophrenia.
    Tamminga CA
    J Clin Psychiatry; 2006; 67 Suppl 9():9-13; discussion 36-42. PubMed ID: 16965183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin receptor responsivity in schizophrenia.
    Kahn RS; Davidson M
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():47-51. PubMed ID: 7911140
    [No Abstract]   [Full Text] [Related]  

  • 12. The neurochemical circuitry of schizophrenia.
    Carlsson A
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S10-4. PubMed ID: 16508890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia.
    Seibyl JP
    J Psychopharmacol; 1997; 11(2):188-9. PubMed ID: 9208382
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurotoxicity of MDMA: neurochemical effects.
    Schmidt CJ; Kehne JH
    Ann N Y Acad Sci; 1990; 600():665-80; discussion 680-1. PubMed ID: 1979217
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ecstasy--effects and toxicity. Distinct risks but uncertain long-term hazards].
    Series H; Lindefors N
    Lakartidningen; 1993 Aug; 90(32-33):2648-52. PubMed ID: 8103135
    [No Abstract]   [Full Text] [Related]  

  • 16. The neurobiology of cognition in schizophrenia.
    Tamminga CA
    J Clin Psychiatry; 2006 Sep; 67(9):e11. PubMed ID: 17081078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of serotonin transmission in schizophrenia.
    Abi-Dargham A
    Int Rev Neurobiol; 2007; 78():133-64. PubMed ID: 17349860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antipsychotic drugs on serotonin receptors.
    Meltzer HY; Nash JF
    Pharmacol Rev; 1991 Dec; 43(4):587-604. PubMed ID: 1685568
    [No Abstract]   [Full Text] [Related]  

  • 19. [Schizophrenia: receptors and clinical aspects].
    Azorin JM
    Encephale; 1997 Apr; 23 Spec No 2():17-9. PubMed ID: 9273301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The involvement of 5-HT1a serotonin receptors in the pathophysiology and pharmacotherapy of schizophrenia].
    Maćkowiak M; Czyrak A; Wedzony K
    Psychiatr Pol; 2000; 34(4):607-21. PubMed ID: 11059260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.